You have read all your free articles, to continue reading subscribe to read the rest of this content.
Swedish radiopharmaceutical production company Alpha Therapy Solutions and Advanced Nuclear Medicine Ingredients S.A., a wholly owned European subsidiary of Telix Pharmaceuticals Limited, have been jointly awarded a 990,000 EUR, a Eurostars-2 research grant from the EUREKA Association. The EurostAlready a subscriber Login You have read all your free articles, to…
Modus Therapeutics secures access to bridge financing from longstanding investor Karolinska Development. Access to this funding ensures that momentum of clinical development of Modus’ lead asset, sevuparin, will be enhanced while the company continues to explore licensing and partnership opportAlready a subscriber Login You have read all your free articles,…
The US Food and Drug Administration has granted Fast Track Designation for the company's lead NOX inhibitor candidate setanaxib for the treatment of patients with the chronic orphan liver disease primary biliary cholangitis (PBC). Setanaxib has previously been granted orphan drug designation for Already a subscriber Login You have read…
Lobsor Pharmaceuticals has reported that following Swedish MPA market approval in October 2018, the Swedish Dental and Pharmaceutical Benefits Agency (TLV) has included Lecigon on Sweden’s list of reimbursed drugs. A major milestone "This marks a major milestone as Sweden becomes the first countAlready a subscriber Login You have read…
